UIC Licenses Anticancer Agent for Melanoma
University of Illinois ChicagoThe University of Illinois at Chicago has licensed the worldwide rights to develop betulinic acid, a compound that in animal tests has shown activity against malignant melanoma, a deadly form of skin cancer, to Advanced Life Sciences, Lemont, Ill.